Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
OxCan
Oxford Cancer Analytics (OXcan) is a medtech company focused on transforming cancer treatment through early detection using advanced proteomics and AI. Their DEcancer platform offers minimally…
OxCan
Oxford Cancer Analytics (OXcan) is a medtech company focused on transforming cancer treatment through early detection using advanced proteomics and AI. Their DEcancer platform offers minimally…
TL;DR
What they do: Develop blood-based proteomic + ML tests for early lung cancer detection
Founded: 2020
Headcount (approx.): 25 employees
Recent financing: Series A ~USD 11M (Jan 2025); total funding ~USD 16.4M
Origin: University of Oxford spinout
Company Overview
Problem Domain
Early detection and staging of lung cancer (biomarker-based diagnostics).
Founded
2020
Industry
Biotechnology
Funding Track Record
1.28 million
Seed round reported as oversubscribed (~£1.28M) with support from the Francis Crick Institute, Civilization Ventures, Oxford Technology Management and angels
11000000
Series A reported at ~USD 11M (~€10M / £10M equivalent) with participation from We Venture Capital and Cross-Border Impact Ventures among others
Investor Signal
“Aurelium Ventures; Brad Wilson; Cancer Research UK; Civilization Ventures; Cross-Border Impact Ventures; DigitalDx Ventures; Eka Ventures; LifeArc; Macmillan Cancer Support; Marcus East; MegaRobo; OKG Capital; Oxford Technology Management; The Francis Crick Institute; We Venture Capital”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week